Squarepoint
ATTO

Squarepoint’s Attovia Therapeutics ATTO Stock Holding History

Squarepoint’s Portfolio ATTO Stock Details ATTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$732K Buy
+42,725
New +$899K ﹤0.01% 3055

Other funds holding ATTO

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Squarepoint's ATTO Position: Q3 2026 in Review

Squarepoint opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 42,725 shares worth $732K. The stake represents ﹤0.01% of the portfolio and ranks #3055 among its holdings.

4 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Squarepoint held 42,725 shares of Attovia Therapeutics worth $732K as of Q3 2026.
  • Attovia Therapeutics was a new Squarepoint position in Q3 2026.
  • Attovia Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3055 holding.
  • 4 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.